Ampliphi Biosciences Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
You have viewed 10 of the 10 daily limit
Subscribe for $29/month to gain full access
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Ampliphi Biosciences Corp
TickerARMP
CIK #0000921114
CUSIP04216R102
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address4870 Sadler Road Suite 300, Glen Allen, VA 23060
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Ampliphi Biosciences Corp 2015-03-30 13.0 M Exemption: 506(b) · Duration: One year or less · Commission: $789,600 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0000921114] 10-K
[0000921114] 10-Q
[0000921114] 3
[0000921114] 4
[0000921114] 5
[0000921114] 8-K
[0000921114] D
[0000921114] SC 13D
[0000921114] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Innoviva Inc Armata Pharmaceuticals Inc [2020-02-14] 16.66
Synthetic Genomics Inc Armata Pharmaceuticals Inc [2019-11-12] 5.2
Corvesta Inc Armata Pharmaceuticals Inc [2019-05-21] 6.4
Delta Dental of Wisconsin Inc Armata Pharmaceuticals Inc [2019-05-21] 21.2
Delta Dental Plan of Michigan Inc Armata Pharmaceuticals Inc [2019-05-17] 12.7
Delta Dental of California Armata Pharmaceuticals Inc [2019-05-10] 0.95
Armistice Capital LLC Ampliphi Biosciences Corp [2018-03-29] 0.0
Sabby Management LLC Ampliphi Biosciences Corp [2018-03-22] 3.89
Empery Asset Management LP Ampliphi Biosciences Corp [2018-01-16] 7.5
Hudson Bay Capital Management LP Ampliphi Biosciences Corp [2017-01-30] 6.9
CVI Investments Inc Ampliphi Biosciences Corp [2016-11-25] 6.8
Empery Asset Management LP Ampliphi Biosciences Corp [2016-06-06] 6.38
Sabby Management LLC Ampliphi Biosciences Corp [2016-06-02] 3.19
Bioscience Managers PTY Ltd Ampliphi Biosciences Corp [2016-03-21] 6.53
Smithyman Anthony Ampliphi Biosciences Corp [2015-04-27] 0.127
Kirk Randal J Ampliphi Biosciences Corp [2015-03-20] 23.7
Kirk Randal J Ampliphi Biosciences Corp [2015-02-13] 25.4
RA Capital Management LLC Ampliphi Biosciences Corp [2014-03-21] 0.9
Broadfin Capital LLC Ampliphi Biosciences Corp [2014-01-03] 7.67
Form 3/4/5 Filer 2011 - 2026
Gilmer Daniel B
AmpliPhi Biosciences Corp
Birx Deborah
Kyme Pierre
Peterson Todd C
House David Duane
Patti Joseph M
Kramer Robin
Odysseas Kostas D
Schlesinger Sarah J
Haimovitz Jules
Rychlik Richard
Averill Julianne
Butler Erin
Theravance Inc
Innoviva Strategic Opportunities LLC
Patrick Todd
Varnum Brian
Morris Duane Alfred
Martin Steven Robert
Bastiani Richard
Cook Jeremy Curnock
Perry Michael S
Bear Richard
Parker H Stewart
Delta Dental of Wisconsin Inc
Renaissance Holding Co
Delta Dental Plan of Michigan Inc
Grint Paul C
Samant Vijay B
Johnson Wendy S
Drapeau Louis
Bilinsky IGOR
Salka Michael Scott
Precigen Inc
Kirk Randal J
Kirk Julian P
Wendt Kelley A
Williams Gwynn
Young Philip J
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Birx Deborah
Common Stock
2026-03-14 Tax withheld 4,919 $10.54 51,846
Kyme Pierre
Common Stock
2026-03-14 Tax withheld 1,030 $10.54 10,856
House David Duane
Stock Options (Right to Buy) · derivative
2026-03-09 Grant 109,885 $0.00
Patti Joseph M
Stock Options (Right to Buy) · derivative
2026-03-09 Grant 25,640 $0.00
Peterson Todd C
Stock Options (Right to Buy) · derivative
2026-03-09 Grant 25,640 $0.00
Odysseas Kostas D
Stock Options (Right to Buy) · derivative
2026-03-09 Grant 25,640 $0.00
Birx Deborah
Stock Options (Right to Buy) · derivative
2026-03-09 Grant 421,226 $0.00
Schlesinger Sarah J
Stock Options (Right to Buy) · derivative
2026-03-09 Grant 25,640 $0.00
Haimovitz Jules
Stock Options (Right to Buy) · derivative
2026-03-09 Grant 25,640 $0.00
Kramer Robin
Stock Options (Right to Buy) · derivative
2026-03-09 Grant 25,640 $0.00
Kyme Pierre
Stock Options (Right to Buy) · derivative
2026-03-09 Grant 183,142 $0.00
Birx Deborah
Common Stock
2025-07-10 Tax withheld 13,637 $2.27 30,956
Birx Deborah
Common Stock
2025-03-14 Tax withheld 6,061 $1.95 11,819
Kyme Pierre
Common Stock
2025-03-14 Tax withheld 1,027 $1.95 2,003
Haimovitz Jules
Stock Options (Right to Buy) · derivative
2025-02-05 Grant 54,343 $0.00
Odysseas Kostas D
Stock Options (Right to Buy) · derivative
2025-02-05 Grant 54,343 $0.00
Schlesinger Sarah J
Stock Options (Right to Buy) · derivative
2025-02-05 Grant 54,343 $0.00
Peterson Todd C
Stock Options (Right to Buy) · derivative
2025-02-05 Grant 54,343 $0.00
Patti Joseph M
Stock Options (Right to Buy) · derivative
2025-02-05 Grant 54,343 $0.00
Kyme Pierre
Stock Options (Right to Buy) · derivative
2025-02-05 Grant 100,000 $0.00
showing 20 of 164 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 45 3,927,411
2025-12-31 36 1,247,603
2025-09-30 28 759,773
2025-06-30 30 735,244
2025-03-31 27 743,098
2024-12-31 25 1,400,554
2024-09-30 25 1,402,821
2024-06-30 24 1,461,325
2024-03-31 25 1,420,699
2023-12-31 26 1,288,987
2023-09-30 23 1,181,869
2023-06-30 23 1,185,533
Form 13F Holdings
Firm Period DFND Voting Shares
Seacrest Wealth Management LLC [2026-06-30] SOLE 0 41,524
Salem Investment Counselors Inc [2026-06-30] SOLE 100 100
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com